Steven C. Quay

Insider Reports History

Location: 22026 20 Th Avenue S E, Suite 102, Bothell, WA
Signature: /s/ Steven C. Quay
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven C. Quay:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
ATOSSA THERAPEUTICS, INC.	President & CEO, Director	Common Stock	22.3K	$17.8K	$0.80	May 21, 2025	By Ensisheim Partners, LLC
ATOSSA THERAPEUTICS, INC.	President & CEO, Director	Common Stock	13.9K	$12.2K	$0.88	May 21, 2025	Direct
ATOSSA THERAPEUTICS, INC.	President & CEO, Director	Stock Option (right to buy)	1.37M			May 15, 2025	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Steven C. Quay

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ATOS	ATOSSA THERAPEUTICS, INC.	May 21, 2025	1	$9.89K	4	May 22, 2025	President & CEO, Director
ATOS	ATOSSA THERAPEUTICS, INC.	May 15, 2025	1	$0	4	May 16, 2025	President & CEO, Director
ATOS	ATOSSA THERAPEUTICS, INC.	Jun 27, 2024	1	$0	4	Jul 1, 2024	President & CEO, Director
ATOS	ATOSSA THERAPEUTICS, INC.	Mar 2, 2023	1	$0	4	Mar 6, 2023	President & CEO, Director
ATOS	ATOSSA THERAPEUTICS, INC.	Feb 24, 2022	1	$0	4	Feb 28, 2022	President & CEO, Director
ATOS	ATOSSA THERAPEUTICS, INC.	May 14, 2021	1	$0	4	May 18, 2021	President & CEO, Director
ATOS	ATOSSA THERAPEUTICS, INC.	May 14, 2021	1	$0	4	May 18, 2021	President & CEO, Director